1. Home
  2. RLMD vs LXEH Comparison

RLMD vs LXEH Comparison

Compare RLMD & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • LXEH
  • Stock Information
  • Founded
  • RLMD 2004
  • LXEH 2001
  • Country
  • RLMD United States
  • LXEH China
  • Employees
  • RLMD N/A
  • LXEH N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • LXEH Other Consumer Services
  • Sector
  • RLMD Health Care
  • LXEH Real Estate
  • Exchange
  • RLMD Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • RLMD 53.4M
  • LXEH 55.2M
  • IPO Year
  • RLMD N/A
  • LXEH 2020
  • Fundamental
  • Price
  • RLMD $1.59
  • LXEH $2.39
  • Analyst Decision
  • RLMD Buy
  • LXEH
  • Analyst Count
  • RLMD 3
  • LXEH 0
  • Target Price
  • RLMD $5.00
  • LXEH N/A
  • AVG Volume (30 Days)
  • RLMD 1.6M
  • LXEH 3.9M
  • Earning Date
  • RLMD 11-06-2025
  • LXEH 09-26-2025
  • Dividend Yield
  • RLMD N/A
  • LXEH N/A
  • EPS Growth
  • RLMD N/A
  • LXEH N/A
  • EPS
  • RLMD N/A
  • LXEH N/A
  • Revenue
  • RLMD N/A
  • LXEH $4,493,795.00
  • Revenue This Year
  • RLMD N/A
  • LXEH N/A
  • Revenue Next Year
  • RLMD N/A
  • LXEH N/A
  • P/E Ratio
  • RLMD N/A
  • LXEH N/A
  • Revenue Growth
  • RLMD N/A
  • LXEH N/A
  • 52 Week Low
  • RLMD $0.24
  • LXEH $1.12
  • 52 Week High
  • RLMD $3.98
  • LXEH $50.08
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 74.57
  • LXEH 65.46
  • Support Level
  • RLMD $1.44
  • LXEH $1.72
  • Resistance Level
  • RLMD $1.72
  • LXEH $2.34
  • Average True Range (ATR)
  • RLMD 0.24
  • LXEH 0.21
  • MACD
  • RLMD 0.05
  • LXEH 0.06
  • Stochastic Oscillator
  • RLMD 86.90
  • LXEH 93.58

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: